-
Neurofilament Light Chain May Be Biomarker of FA Severity in Younger Patients
Neurofilament light chain may be a biomarker of disease severity and response to treatment among people with FA, particularly younger ones. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.